IMR Press / CEOG / Volume 49 / Issue 1 / DOI: 10.31083/j.ceog4901022
Open Access Original Research
Human papillomavirus vaccine uptake in South Korea
Show Less
1 Department of Obstetrics and Gynecology, Chungbuk National University Hospital, 13620 Cheongju si, Republic of Korea
2 Department of Obstetrics and Gynecology, CHA Gangnam Medical Center, CHA University School of Medicine, 06135 Seoul, Republic of Korea
3 Department of Obstetrics and Gynecology, Kyung Hee Medical Center, College of Medicine, Kyung Hee University Hospital, 02447 Seoul, Republic of Korea
4 Statistics Support Part, Medical Science Research Institute, Kyung Hee University Hospital, 02447 Seoul, Republic of Korea
5 Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam si, 13620 Gyeonggi do, Republic of Korea

Academic Editor: Haim Dahan

Clin. Exp. Obstet. Gynecol. 2022, 49(1), 22;
Submitted: 12 April 2021 | Revised: 6 September 2021 | Accepted: 14 September 2021 | Published: 18 January 2022
Copyright: © 2022 The Author(s). Published by IMR Press.
This is an open access article under the CC BY 4.0 license.

Background: This study aimed to assess the human papillomavirus (HPV) vaccine uptake rate in South Korean women and to identify factors affecting vaccination rate before initiation of the national HPV vaccination as a National Immunization Program (NIP) in Korea. Materials and methods: We conducted online survey in February 2016 with questions to 2000 women aged between 9 and 59 years in South Korea by distribution of age and region, to assess HPV uptake and associated correlates such as age, residential region, education, and socioeconomic status. Results: The overall HPV vaccine received at least 1 dose rate was 23.1%, and the highest rate of vaccination was observed in women aged 20–29 years (38.6%), followed by those aged 30–39 years (36.9%), 9–19 years (16.9%), 40–49 years (14.2%), and 50–59 years (12.5%). Factors affecting HPV vaccination included metropolitan cities (odds ratio [OR] = 1.44, 95% confidence interval [CI], 1.15–1.80), university graduate (OR = 1.45, 95% CI, 1.06–2.00), regular influenza vaccination (OR = 2.11, 95% CI, 1.64–2.70), visited clinic within the last 6 months (OR = 1.73, 95% CI, 1.20–2.51) and high family income (OR = 1.55, 95% CI, 1.01–2.37). Conclusion: HPV vaccine uptake is low in South Korean women. Correct publicity, education and economic support programs for HPV vaccine could play an important role in increasing HPV vaccine uptake in South Korea.

Human papillomavirus
Vaccine uptake
Back to top